Investors must take note of Bruker Corp’s (BRKR) performance last week, which was 5.28%.

On Monday, Bruker Corp (NASDAQ: BRKR) opened higher 4.22% from the last session, before settling in for the closing price of $58.96. Price fluctuations for BRKR have ranged from $48.07 to $94.86 over the past 52 weeks.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


Sponsored

It was noted that within the last five years, the titan of the Healthcare sector saw sales topped by 9.74%. Company’s average yearly earnings per share was noted -7.55% at the time writing. With a float of $102.92 million, this company’s outstanding shares have now reached $151.59 million.

The extent of productivity of a business whose workforce counts for 9707 workers is very important to gauge. In terms of profitability, gross margin is 48.88%, operating margin of 10.13%, and the pretax margin is 12.08%.

Bruker Corp (BRKR) Insider and Institutional Ownership

A key investor’s attitude towards the stock of the Medical Devices industry is another important factor to consider. The insider ownership of Bruker Corp is 32.11%, while institutional ownership is 79.24%. The most recent insider transaction that took place on Dec 02 ’24, was worth 193,683. In this transaction Director of this company sold 3,350 shares at a rate of $57.82, taking the stock ownership to the 80,904 shares. Before that another transaction happened on Dec 02 ’24, when Company’s Director proposed sale 3,350 for $57.82, making the entire transaction worth $193,683.

Bruker Corp (BRKR) Latest Financial update

According to the Wall Street analysts, stocks earnings will be around -7.55% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 15.00% during the next five years compared to 20.48% growth over the previous five years of trading.

Bruker Corp (NASDAQ: BRKR) Trading Performance Indicators

Check out the current performance indicators for Bruker Corp (BRKR). In the past quarter, the stock posted a quick ratio of 0.73. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 2.90. Likewise, its price to free cash flow for the trailing twelve months is 59.94.

For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 2.08, a number that is poised to hit 0.73 in the next quarter and is forecasted to reach 2.72 in one year’s time.

Technical Analysis of Bruker Corp (BRKR)

The latest stats from [Bruker Corp, BRKR] show that its last 5-days average volume of 1.18 million was superior to 1.11 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 61.92%. Additionally, its Average True Range was 2.40.

During the past 100 days, Bruker Corp’s (BRKR) raw stochastic average was set at 53.80%, which indicates a significant decrease from 96.68% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 52.01% in the past 14 days, which was higher than the 39.91% volatility it showed in the past 100 days.

At the time of writing, stock’s 50-day Moving Average is $59.67, while its 200-day Moving Average is $69.87. Now, the first resistance to watch is $62.64. This is followed by the second major resistance level at $63.82. The third major resistance level sits at $65.74. If the price goes on to break the first support level at $59.54, it is likely to go to the next support level at $57.62. The third support level lies at $56.44 if the price breaches the second support level.

Bruker Corp (NASDAQ: BRKR) Key Stats

There are currently 151,598K shares outstanding in the company with a market cap of 9.39 billion. Presently, the company’s annual sales total 2,965 M according to its annual income of 427,200 K. Last quarter, the company’s sales amounted to 864,400 K and its income totaled 40,900 K.